Mercury rising: Cinven strikes new deal with HgCapital
HgCapital has sold Mercury Pharma to Cinven for £465m (€590.6m), netting the seller a 4x return after delisting the generic pharmaceuticals player less than three years ago for £179m.
Hg
HgCapital has sold Mercury Pharma to Cinven for £465m (€590.6m), netting the seller a 4x return after delisting the generic pharmaceuticals player less than three years ago for £179m.
Hg